Literature DB >> 25863168

CB1 receptors modulate affective behaviour induced by neuropathic pain.

Ildikó Rácz1, Elisa Nent2, Edda Erxlebe2, Andreas Zimmer3.   

Abstract

Patients suffering from chronic pain are often diagnosed with a psychiatric condition, in particular generalized anxiety and major depression. The underlying pathomechanisms contributing to this comorbidity, however, are not entirely clear. In this manuscript we have focussed on the potential role of the cannabinoid receptor CB1, because it is known to modulate neuronal circuits contributing to chronic pain states and affective behaviours. For this purpose we analysed the consequences of a partial sciatic nerve ligation on anxiety- and depression-related behaviours in mice lacking CB1 receptors. Our results show that the development of mechanical hypersensitivity was similar in CB1 deficient mice and wild type controls. However, CB1 knockouts showed much more pronounced behavioural manifestations of anxiety-related behaviours in the light-dark and zero-maze tests, sucrose anhedonia, and disturbed home-cage activity. These results indicate that the endocannabinoid system affects chronic pain-induced mood changes through CB1 receptors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; CB1 receptor; Depression; Endocannabinoid system; Neuropathic pain; Partial sciatic nerve ligation

Mesh:

Substances:

Year:  2015        PMID: 25863168     DOI: 10.1016/j.brainresbull.2015.03.005

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

Review 1.  Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain.

Authors:  Samuel D Banister; Kaavya Krishna Kumar; Vineet Kumar; Brian K Kobilka; Sanjay V Malhotra
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

Review 2.  Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?

Authors:  Amber L Milligan; Thomas A Szabo-Pardi; Michael D Burton
Journal:  J Dual Diagn       Date:  2019-10-09

3.  Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review.

Authors:  Laura Colino; Javier Herranz-Herrer; Elena Gil-Benito; Teresa Ponte-Lopez; Pablo Del Sol-Calderon; Maria Rodrigo-Yanguas; María Gil-Ligero; Antonio J Sánchez-López; Jose de Leon; Hilario Blasco-Fontecilla
Journal:  Curr Psychiatry Rep       Date:  2018-03-15       Impact factor: 5.285

Review 4.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

Review 5.  Medical Cannabis for Neuropathic Pain.

Authors:  Gemayel Lee; Brittany Grovey; Tim Furnish; Mark Wallace
Journal:  Curr Pain Headache Rep       Date:  2018-02-01

6.  CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain.

Authors:  Elisa Nent; Chihiro Nozaki; Anne-Caroline Schmöle; David Otte; Andreas Zimmer
Journal:  Sci Rep       Date:  2019-05-16       Impact factor: 4.379

7.  The influence of rat strain on the development of neuropathic pain and comorbid anxio-depressive behaviour after nerve injury.

Authors:  Sara Hestehave; Klas S P Abelson; Tina Brønnum Pedersen; David P Finn; Daniel R Andersson; Gordon Munro
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

Review 8.  High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity.

Authors:  Marie Fitzgibbon; David P Finn; Michelle Roche
Journal:  Int J Neuropsychopharmacol       Date:  2015-09-05       Impact factor: 5.176

9.  Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity.

Authors:  Alexandra Sideris; Boris Piskoun; Lori Russo; Monica Norcini; Thomas Blanck; Esperanza Recio-Pinto
Journal:  Mol Pain       Date:  2016-05-20       Impact factor: 3.395

10.  Involvement of leptin signaling in the development of cannabinoid CB2 receptor-dependent mirror image pain.

Authors:  Chihiro Nozaki; Elisa Nent; Andras Bilkei-Gorzo; Andreas Zimmer
Journal:  Sci Rep       Date:  2018-07-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.